InvestorsObserver
×
News Home

Is Akebia Therapeutics Inc (AKBA) a Stock to Watch This Week?

Monday, January 25, 2021 10:16 AM | InvestorsObserver Analysts

Mentioned in this article

Is Akebia Therapeutics Inc (AKBA) a Stock to Watch This Week?

The market has been high on Akebia Therapeutics Inc (AKBA) stock recently. AKBA gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Akebia Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on AKBA!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.

Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.

InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.

Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With AKBA Stock Today?

Akebia Therapeutics Inc (AKBA) stock is trading at $3.90 as of 10:15 AM on Monday, Jan 25, a rise of $0.54, or 16.12% from the previous closing price of $3.36. The stock has traded between $3.46 and $3.92 so far today. Volume today is less active than usual. So far 2,533,026 shares have traded compared to average volume of 6,146,464 shares.

To screen for more stocks like Akebia Therapeutics Inc click here.

More About Akebia Therapeutics Inc

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

Click Here to get the full Stock Score Report on Akebia Therapeutics Inc (AKBA) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App